2010DOAJ (DOAJ: Directory of Open Access Journals)Requires access

MOLECULAR DIAGNOSIS OF DUCHENNE/BECKER MUSCULAR DYSTROPHY: ANALYSIS OF EXONS DELETION AND CARRIER DETECTION

Mohammad Taghi Akbari, Shohreh Zare Karizi, Shahriar Nafisi, Zamani Gholam Reza

Open publisher page 0 citations

Abstract

Objective: Duchenne and Becker Muscular Dystrophy (DMD and BMD) are X-linked conditionsresulting from a defect in the dystrophin gene located at Xp21.2. DMD is the mostfrequent neuromuscular disease in humans (1/3500 male newborns). In approximately65% of DMD and BMD patients, deletions in the dystrophin gene have been identified asthe molecular determinant. The frequency and distribution of dystrophin gene deletions inDMD/BMD patients from different populations are different.The aim of this study was to delineate various types of deleted exons and their frequencyin affected male patients and identification of carrier females by linkage analysis.Materials and Methods: In this study 100 unrelated patients with DMD/BMD were studiedfor intragenic deletions in 28 exons and the promoter region of the dystrophin geneusing multiplex PCR. We also performed linkage analysis within the dystrophin gene utilizing8 short tandem repeat markers.Results: Fifty-two (52%) patients showed intragenic deletions. A total of 81% of the deletionswere located at the distal hot spot region (44-55 exons) and 19% of the deletionswere located at the proximal region (exon 2-19). The most frequent deleted exons were47(16%), 48 and 46 (11%).Most of the STR markers showed heterozygosity in the families studied. The linkageanalysis was useful for detecting carrier status.Conclusion: The present study suggests that intragenic dystrophin gene deletions occurwith the same frequency in Iranian patients compared with other ethnic groups.

About this research paper

What this paper is about

Objective: Duchenne and Becker Muscular Dystrophy (DMD and BMD) are X-linked conditionsresulting from a defect in the dystrophin gene located at Xp21.2. DMD is the mostfrequent neuromuscular disease in humans (1/3500 male newborns). In approximately65% of DMD and BMD patients, deletions in the dystrophin gene have been identified asthe molecular determinant. The frequency and distribution of dystrophin gene deletions inDMD/BMD patients from different populations are different.The aim of this study was to delineate various types of deleted exons and their frequencyin affected male patients and identification of carrier females by linkage analysis.Materials and Methods: In this study 100 unrelated patients with DMD/BMD were studiedfor intragenic deletions in 28 exons and the promoter region of the dystrophin geneusing multiplex PCR. We also performed linkage analysis within the dystrophin gene utilizing8 short tandem repeat markers.Results: Fifty-two (52%) patients showed intragenic deletions. A total of 81% of the deletionswere located at the distal hot spot region (44-55 exons) and 19% of the deletionswere located at the proximal region (exon 2-19). The most frequent deleted exons were47(16%), 48 and 46 (11%).Most of the STR markers showed heterozygosity in the families studied. The linkageanalysis was useful for detecting carrier status.Conclusion: The present study suggests that intragenic dystrophin gene deletions occurwith the same frequency in Iranian patients compared with other ethnic groups.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: Duchenne and Becker Muscular Dystrophy (DMD and BMD) are X-linked conditionsresulting from a defect in the dystrophin gene located at Xp21.2. DMD is the mostfrequent neuromuscular disease in humans (1/3500 male newborns). In approximately65% of DMD and BMD patients, deletions in the dystrophin gene have been identified asthe molecular determinant. The frequency and distribution of dystrophin gene deletions inDMD/BMD patients from different populations are different.The aim of this study was to delineate various types of deleted exons and their frequencyin affected male patients and identification of carrier females by linkage analysis.Materials and Methods: In this study 100 unrelated patients with DMD/BMD were studiedfor intragenic deletions in 28 exons and the promoter region of the dystrophin geneusing multiplex PCR. We also performed linkage analysis within the dystrophin gene utilizing8 short tandem repeat markers.Results: Fifty-two (52%) patients showed intragenic deletions. A total of 81% of the deletionswere located at the distal hot spot region (44-55 exons) and 19% of the deletionswere located at the proximal region (exon 2-19). The most frequent deleted exons were47(16%), 48 and 46 (11%).Most of the STR markers showed heterozygosity in the families studied. The linkageanalysis was useful for detecting carrier status.Conclusion: The present study suggests that intragenic dystrophin gene deletions occurwith the same frequency in Iranian patients compared with other ethnic groups.

Key concepts: Exon, Duchenne muscular dystrophy, Dystrophin, Genetics, Muscular dystrophy, Loss of heterozygosity, Biology, Multiplex ligation-dependent probe amplification

Related papers

Back to paper searchBrowse research topicsOriginal source
MOLECULAR DIAGNOSIS OF DUCHENNE/BECKER MUSCULAR DYSTROPHY: ANALYSIS OF EXONS DELETION AND CARRIER DETECTION — Research Paper | ScholarLens